ATE276771T1 - Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien - Google Patents

Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien

Info

Publication number
ATE276771T1
ATE276771T1 AT98933166T AT98933166T ATE276771T1 AT E276771 T1 ATE276771 T1 AT E276771T1 AT 98933166 T AT98933166 T AT 98933166T AT 98933166 T AT98933166 T AT 98933166T AT E276771 T1 ATE276771 T1 AT E276771T1
Authority
AT
Austria
Prior art keywords
group
pathogen inactivating
inactivating compound
red blood
pathogen
Prior art date
Application number
AT98933166T
Other languages
English (en)
Inventor
David Cook
Adonis Stassinopoulos
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Application granted granted Critical
Publication of ATE276771T1 publication Critical patent/ATE276771T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • External Artificial Organs (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT98933166T 1998-01-06 1998-07-06 Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien ATE276771T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7059798P 1998-01-06 1998-01-06
PCT/US1998/013931 WO1999034839A1 (en) 1998-01-06 1998-07-06 Methods for quenching pathogen inactivators in biological materials

Publications (1)

Publication Number Publication Date
ATE276771T1 true ATE276771T1 (de) 2004-10-15

Family

ID=22096274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933166T ATE276771T1 (de) 1998-01-06 1998-07-06 Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien

Country Status (11)

Country Link
US (3) US6270952B1 (de)
EP (1) EP1045704B1 (de)
JP (2) JP4643004B2 (de)
CN (1) CN1203900C (de)
AT (1) ATE276771T1 (de)
AU (1) AU745209B2 (de)
CA (1) CA2317603A1 (de)
DE (1) DE69826521T2 (de)
ES (1) ES2224415T3 (de)
HK (1) HK1034682A1 (de)
WO (1) WO1999034839A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
EP1045704B1 (de) * 1998-01-06 2004-09-22 Cerus Corporation Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
US7611831B2 (en) * 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US6369048B1 (en) 1998-01-12 2002-04-09 V.I. Technologies, Inc. Methods and compositions for inactivating viruses
US20030073650A1 (en) * 1998-07-21 2003-04-17 Heather Reddy Method and apparatus for inactivation of biological contaminants using photosensitizers
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US7220747B2 (en) * 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
AU2001266683A1 (en) * 2000-05-31 2001-12-11 Cerus Corporation Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
EP1365750A2 (de) * 2000-12-21 2003-12-03 Cerus Corporation Methoden zur inaktivierung von pathogenen in biomaterialien
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
US20030141260A1 (en) * 2001-12-28 2003-07-31 Frank Corbin Oxygen-enhanced pathogen inactivation
US7172905B2 (en) 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US7235392B2 (en) * 2001-12-07 2007-06-26 The Ohio State University Research Foundation Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
CA2492103A1 (en) * 2002-05-10 2004-05-27 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
JP4839209B2 (ja) * 2003-02-06 2011-12-21 アンザ セラピューティクス，インコーポレイテッド 改変された自由生活微生物、ワクチン組成物、およびそれらの使用方法
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
PT1592441E (pt) 2003-02-06 2012-05-21 Aduro Biotech Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
CA2585621C (en) 2004-10-29 2015-12-15 Cerus Corporation Improved quenching methods for red blood cell inactivation process
BRPI0911176B8 (pt) 2008-04-09 2021-05-25 Cerus Corp método de tratar uma composição de célula vermelha sanguínea, composição de célula vermelha sanguínea, e método de reduzir a desidratação em uma composição de célula vermelha sanguínea
JP2011523553A (ja) 2008-05-19 2011-08-18 アデュロ バイオテック ＰｒｆＡ＊変異株リステリアを含む組成物およびその使用法
CN102481385B (zh) * 2009-06-30 2016-01-27 3M创新有限公司 光活化抗微生物制品及其使用方法
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
EA201790265A1 (ru) 2014-07-23 2017-07-31 Сирус Корпорейшн Способы получения тромбоцит-содержащих продуктов
PT3313418T (pt) 2015-06-26 2024-06-06 Cerus Corp Composições de crioprecipitado e métodos de preparação das mesmas
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
EP3559665A1 (de) 2016-12-23 2019-10-30 Cerus Corporation Systeme und verfahren für tests und screenings unter verwendung von substraten mit daran gebundenen verbindungen
US20190321407A1 (en) 2016-12-31 2019-10-24 Cerus Corporation Compositions and methods for preparation of red blood cells
CN110573169A (zh) 2017-03-03 2019-12-13 塞鲁斯公司 制备病原体灭活的血小板组合物的试剂盒和方法
CA3087253A1 (en) 2017-12-29 2019-07-04 Cerus Corporation Systems and methods for treating biological fluids
US20220031917A1 (en) * 2018-09-20 2022-02-03 Cerus Corporation Methods and kits for preparing pathogen-inactivated whole blood
EP3986499A2 (de) 2019-06-22 2022-04-27 Cerus Corporation Biologische flüssigkeitsbehandlungssysteme
CN114269394A (zh) 2019-06-28 2022-04-01 塞鲁斯公司 用于实现生物流体处理装置的系统和方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281579A (en) * 1883-07-17 Electric valve
US2402665A (en) 1942-11-12 1946-06-25 Du Pont Chemical process
US2402655A (en) 1943-09-22 1946-06-25 Miller Pottery Engineering Co Pottery slip-casting apparatus
IT1093275B (it) 1978-01-26 1985-07-19 Snam Progetti Composizione adatta alla purificazione del sangue e suoi impieghi
US4337269A (en) 1979-07-23 1982-06-29 Sutton Laboratories, Inc. Preservative compositions
US4748120A (en) 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5281579A (en) 1984-03-23 1994-01-25 Baxter International Inc. Purified virus-free hemoglobin solutions and method for making same
US4971760A (en) 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US4944920A (en) 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
US4920143A (en) 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5055485A (en) 1988-12-02 1991-10-08 New York Blood Center, Inc. Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
US5753258A (en) 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
GB9218581D0 (en) 1992-09-02 1992-10-14 Pall Corp Removal of unwanted fluids from processed blood products
KR960703167A (ko) 1993-06-23 1996-06-19 존 더블유. 아담슨 혈액내 바이러스 불활성화 시스템(system for viral inactivation of blood)
US5591350A (en) 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
SE9402472L (sv) * 1994-07-13 1996-01-14 Forskarpatent I Linkoeping Ab Modifierade ytor
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5660731A (en) 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
US5691132A (en) * 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US5637451A (en) 1995-03-29 1997-06-10 New York Blood Center, Inc. Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells
US6177441B1 (en) * 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
WO1996039818A1 (en) * 1995-06-07 1996-12-19 Cerus Corporation Treating red blood cell solutions with anti-viral agents
CA2221733A1 (en) * 1995-06-07 1996-12-19 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
WO1996040857A1 (en) 1995-06-07 1996-12-19 Cerus Corporation Methods and devices for the removal of psoralens from blood products
CA2198085A1 (en) 1995-06-29 1997-01-23 Hemasure, Inc. Inactivation of pathogens using hydroxymethylamines
US6114108A (en) 1995-08-29 2000-09-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of viral nucleic acids
US6136586A (en) 1995-08-29 2000-10-24 Vi Technologies, Inc. Methods for the selective modification of viral nucleic acids
DE69627202T2 (de) 1995-11-06 2003-11-13 New York Blood Center, Inc. Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht
AU1085697A (en) 1995-11-21 1997-06-11 Pall Corporation Inactivation method and system in biological fluids
US6350467B1 (en) * 1996-12-31 2002-02-26 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
US6093725A (en) * 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
AU744089C (en) * 1997-01-06 2003-07-31 Cerus Corporation Frangible compounds for pathogen inactivation
EP1045704B1 (de) * 1998-01-06 2004-09-22 Cerus Corporation Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
US6150109A (en) 1999-01-25 2000-11-21 V. I. TECHNOLOGIES, Inc. Lipophilic quenching of viral inactivating agents
CA2585621C (en) * 2004-10-29 2015-12-15 Cerus Corporation Improved quenching methods for red blood cell inactivation process

Also Published As

Publication number Publication date
WO1999034839A1 (en) 1999-07-15
EP1045704B1 (de) 2004-09-22
HK1034682A1 (en) 2001-11-02
AU745209B2 (en) 2002-03-14
JP2002500204A (ja) 2002-01-08
ES2224415T3 (es) 2005-03-01
US6270952B1 (en) 2001-08-07
JP2010248245A (ja) 2010-11-04
US20040180321A1 (en) 2004-09-16
DE69826521T2 (de) 2005-09-29
CN1284886A (zh) 2001-02-21
US7293985B2 (en) 2007-11-13
US6709810B2 (en) 2004-03-23
US20020028432A1 (en) 2002-03-07
AU8289198A (en) 1999-07-26
DE69826521D1 (de) 2004-10-28
JP4643004B2 (ja) 2011-03-02
CN1203900C (zh) 2005-06-01
CA2317603A1 (en) 1999-07-15
EP1045704A1 (de) 2000-10-25

Similar Documents

Publication Publication Date Title
ATE276771T1 (de) Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
HK1109594A1 (en) Improved quenching methods for red blood cell inactivation process
ATE210192T1 (de) VERFAHREN ZUR DIREKTEN SEQUENZIERUNG WÄHREND ßTEMPLATEß-AMPLIFIKATION
EP0668777A4 (de) Prostata-spezifisches membranantigen.
ATE191515T1 (de) Verfahren und zusammensetzungen zum analysieren von nukleinsäuremolekulen mittels bemessungstechniken
ES2180416A1 (es) Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
ES2182297T3 (es) Deteccion y modulacion de lo inhibidores de las proteinas de la apoptosis (iaps) y de los polipeptidos anti-apoptoticos afines (naip) para la diagnosis y tratamiento de enfermedades proliferativas.
EP1961826A3 (de) Verfahren zur direkten Sequenzierung von Nukleinsäuren
DE69607830D1 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
DE59800705D1 (de) Vorrichtung zum automatischen durchführen von chemischen bzw. biologischen verfahren
ATE260988T1 (de) Vorrichtung und verfahren zur durchführung und überwachung von polymerase kettenreaktionen
DE69636122D1 (de) Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren
DE69524083D1 (de) Stoffen und verfahren zum nachweis von mycobakterium tuberculosis
DE602004031152D1 (de) Verfahren und system zum analysieren von reaktione
FI953990A (fi) Menetelmä nukleiinihappomonistusreaktiotuotteen tekemiseksi kykenemät-tömäksi olemaan lisämonistuksen kohteena, diagnostinen määritysmenetelmä, jossa tätä menetelmää käytetään, ja menetelmän tai määrityksen toteutukseen sopiva testipakkaus ja säiliö
NO870794L (no) FremgangsmŸte til kvantitativ bestemmelse av nukleinsyremolekyler og reagenspakke til bruk ved utfelse av fremgang smŸten.
DE69531487D1 (de) Methode zur eliminierung von sequenzierartefakten
DE59606129D1 (de) Verfahren und verbindungen zur detektion von analyten mittels remanenzmessung und deren verwendung
ATE357516T1 (de) Modulation molekularer wechselwirkungspositionen in rns und anderen biomolekülen
AU5423600A (en) Apparatus, system and method for automated execution and analysis of biological and chemical reactions
Kolpashchikov et al. Sensitized photomodification of mammalian DNA polymerase β. A new approach for highly selective affinity labeling of polymerases
WO2001030986A3 (en) Human pif1 dna helicase and uses thereof
WO2001026536A3 (en) Methods of diagnosing and treating hepatic cell proliferative disorders
WO2002087606A3 (en) Modulators of the hypocretin system and methods of screening therefor
ATE280839T1 (de) Oligonukleotid primer zur effizienten reversen transkription von hepatitis c virus (hcv) rns und verfahren zu deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties